ABC | Volume 114, Nº5, Maio 2020

Arq Bras Cardiol. 2020; 114(5):943-987 Diretrizes Diretriz Brasileira de Reabilitação Cardiovascular – 2020 care professionals from the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association. Circulation. 2012;126(21):2535-43. 34. Hamm LF, Sanderson BK, Ades PA, Berra K, Kaminsky LA, Roitman JL, et al. Core competencies for cardiac rehabilitation/secondary prevention professionals: 2010 update: position statement of the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev. 2011;31(1):2-10. 35. GonzalezMM, Timerman S, Gianotto-Oliveira R, Polastri TF, CanesinMF, Schimidt A, et al. I Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2013;101(2 Suppl 3):1-221. 36. Bernoche C, Timerman S, Polastri TF, Giannetti NS, Siqueira AWS, Piscopo A, et al. Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol. 2019;113(3):449-663. 37. Medicine ACoS. ACSM's Guidelines for Exercise Testing and Prescription. 10th ed. Philadelphia: Lippincott Williams &Wilkins; 2017. 38. Xu K, Soucat A, Kutzin J, Brindley C, Maele NV, Toure H, et al. Public Spending on Health: A Closer Look at Global Trends: Geneva: World Health Organization; 2018. 39. Benjamin EJ, BlahaMJ, Chiuve SE, CushmanM, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146-e603. 40. Siqueira ASE, Siqueira-Filho AG, Land MGP. Análise do Impacto Econômico das Doenças Cardiovasculares nos Últimos Cinco Anos no Brasil. Arq Bras Cardiol. 2017;109(1):39-46. 41. Brasil.Ministério da Saúde. Datasus. Sistema de informações hospitalares. Internações e valor total de internações segundo capítulo CID-10. Brasilia;2018. 42. Duncan BB, Stevens A, Schmidt MI. Mortalidade por doenças crônicas no Brasil: situação em 2010 e tendências de 1991 a 2010. 2012. In: Brasil. Ministério da Saúde Saúde Brasil 2011: uma análise da situação de saúde e a vigilância da saúde da mulher. Brasilia; 2018. 43. Marques LP, Confortin SC. Doenças do Aparelho Circulatório: Principal Causa de Internações de Idosos no Brasil entre 2003 e 2012. Rev Bras Ciênc Saúde.2015;16(4):567-75. 44. Soto PHT, Raitz GM, Bolsoni LL, Costa CKF, Yamaguchi MU, Massuda EM. MorbidadesecustoshospitalaresdoSistemaÚnicodeSaúdeparadoenças crônicas. Rev Rene. 2015;16(4):567-75. 45. Global Burden of Disease Study. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800. 46. MogheiM,Turk-AdawiK,IsaranuwatchaiW,SarrafzadeganN,OhP,Chessex C, et al. Cardiac rehabilitation costs. Int J Cardiol. 2017;244:322-8. 47. Turk-Adawi K, Sarrafzadegan N, Grace SL. Global availability of cardiac rehabilitation. Nat Rev Cardiol. 2014;11(10):586-96. 48. Bailly L, Mosse P, Diagana S, Fournier M, d'Arripe-Longueville F, Diagana O, et al. "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease. BMC Cardiovasc Disord. 2018;18(1):225. 49. Rebelo FP, Garcia Ados S, Andrade DF, Werner CR, Carvalho T. Resultado clínico e econômico de um programa de reabilitação cardiopulmonar e metabólica. Arq Bras Cardiol. 2007;88(3):321-8. 50. Edwards K, Jones N, Newton J, Foster C, Judge A, Jackson K, et al. The cost- effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature. Health Econ Rev. 2017;7(1):37. 51. Brasil. Ministério da Saúde. Avaliação econômica em saúde: desafios para a gestão no Sistema Único de Saúde. 2008. Brasília;2018. 52. Secoli SR, Eidi Nita M, Ono-Nita SK, Nobre M. Avaliação de tecnologia em saúde. II. A análise de custo-efetividade. Arq Gastroenterol. 2010;47(4):329-33. 53. Georgiou D, Chen Y, Appadoo S, Belardinelli R, Greene R, Parides MK, et al. Cost-effectiveness analysis of long-termmoderate exercise training in chronic heart failure. Am J Cardiol. 2001;87(8):984-8; A4. 54. Shields GE, Wells A, Doherty P, Heagerty A, Buck D, Davies LM. Cost- effectiveness of cardiac rehabilitation: a systematic review. Heart. 2018;104(17):1403-10. 55. Hearts: technical package for cardiovascular disease management in primary health care.: Geneva: World Health Organization; 2016. 56. Oldridge NB, Pakosh MT, Thomas RJ. Cardiac rehabilitation in low- and middle-income countries: a review on cost and cost-effectiveness. Int Health. 2016;8(2):77-82. 57. Kuhr EM, Ribeiro RA, Rohde LE, Polanczyk CA. Cost-effectiveness of supervised exercise therapy in heart failure patients. Value Health. 2011;14(5 Suppl 1):S100-7. 58. Kotseva K, Ryden L, De Backer G, De Bacquer D, Wood D. EURObservational research programme: EUROASPIRE. Eur Heart J. 2015;36(16):950-1. 59. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol. 2008;51(17):1619-31. 60. AdesPA,PashkowFJ,FletcherG,PinaIL,ZohmanLR,NestorJR.Acontrolled trialofcardiacrehabilitation inthehomesettingusingelectrocardiographic and voice transtelephonic monitoring. AmHeart J. 2000;139(3):543-8. 61. Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K, et al. Home- based versus centre-based cardiac rehabilitation. CochraneDatabase Syst Rev. 2017;6:CD007130. 62. Jolly K, Taylor R, Lip GY, Greenfield S, Raftery J, Mant J, et al. The BirminghamRehabilitation UptakeMaximisation Study (BRUM). Home- based compared with hospital-based cardiac rehabilitation in a multi- ethnic population: cost-effectiveness and patient adherence. Health Technol Assess. 2007;11(35):1-118. 63. Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS. Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ. 2010;340:b5631. 64. Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study. Eur J Prev Cardiol. 2017;24(12):1260-73. 65. Lear SA, Singer J, Banner-Lukaris D, Horvat D, Park JE, Bates J, et al. Randomized trial of a virtual cardiac rehabilitation program delivered at a distanceviatheInternet.CircCardiovascQualOutcomes.2014;7(6):952-9. 66. Milewski K, Malecki A, Orszulik-Baron D, Kachel M, Hirnle P, Orczyk M, et al. The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial. Cardiol J. 2019;26(5):594-603 67. National Audit of Cardiac Rehabilitation (NACR) Quality and Outcomes Report 2018: New york: The British Heart Foundation; 2018. 68. EndoN, Goto A, Suzuki T, Matsuda S, Yasumura S. Factors associatedwith enrollment and adherence in outpatient cardiac rehabilitation in Japan. J Cardiopulm Rehabil Prev. 2015;35(3):186-92. 69. Phillips LM, Hachamovitch R, Berman DS, Iskandrian AE, Min JK, Picard MH, et al. Lessons learned fromMPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. J Nucl Cardiol. 2013;20(6):969-75. 978